PMGC HOLDINGS INC. Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current
PMGC HOLDINGS INC. (ELAB) had Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current of $94.57 thousand as of 2025-01-16, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Disposal Group, Including Discontinued Operation, Assets, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent · last filed 2026-03-30
- 2025-01-16: Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current $94.57K.
- 2024-12-31: Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current $137.88K.
- 2023-12-31: Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current $1.07M.
- 2023-09-30: Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current $302.83M.
| Period end | Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current | Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current as first filed |
|---|---|---|
| 2025-01-16 | $94.57K 10-K · filed 2026-03-30 | |
| 2024-12-31 | $137.88K 10-K · filed 2026-03-30 | |
| 2023-12-31 | $1.07M 10-K · filed 2024-03-29 | |
| 2023-09-30 | $302.83M 10-Q · filed 2023-12-11 | |
| 2022-12-31 | $164.19K 10-K · filed 2024-03-29 | $164.19M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |